Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | Kala Pharmaceuticals, Inc. KALA | RA Capital Management, L.P. | 247,792 8.530% | -74,020 (-23.00%) | Filing History |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | Kala Pharmaceuticals, Inc. KALA | RA Capital Management, L.P. | 321,812 11.080% | -114,773 (-26.29%) | Filing History |
| 2022-05-25 4:29 pm Purchase | 2022-05-15 | 13G | Celcuity Inc. CELC | RA Capital Management, L.P. | 1,486,471 9.900% | 1,486,471 (New Position) | Filing History |
| 2022-05-20 4:30 pm Purchase | 2022-05-10 | 13D | PepGen Inc. PEPG | RA Capital Management, L.P. | 8,131,952 36.300% | 8,131,952 (New Position) | Filing History |
| 2022-05-16 4:33 pm Sale | 2022-05-16 | 13G | Zogenix, Inc. ZGNX | RA Capital Management, L.P. | 0 0.000% | -3,333,700 (Position Closed) | Filing History |
| 2022-05-16 4:32 pm Sale | 2022-05-16 | 13G | Phathom Pharmaceuticals, Inc. PHAT | RA Capital Management, L.P. | 0 0.000% | -3,115,008 (Position Closed) | Filing History |
| 2022-05-16 4:31 pm Sale | 2022-05-16 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA Capital Management, L.P. | 0 0.000% | -2,378,325 (Position Closed) | Filing History |
| 2022-05-16 4:30 pm Sale | 2022-05-16 | 13G | Olema Pharmaceuticals, Inc. OLMA | RA Capital Management, L.P. | 0 0.000% | -2,150,404 (Position Closed) | Filing History |
| 2022-05-02 4:30 pm Purchase | 2022-04-28 | 13D | Nkarta, Inc. NKTX | RA Capital Management, L.P. | 7,832,340 16.200% | 2,227,211 (+39.74%) | Filing History |
| 2022-04-28 4:58 pm Purchase | 2022-04-18 | 13G | NanoString Technologies, Inc. NSTGQ | RA Capital Management, L.P. | 3,517,694 7.700% | 3,517,694 (New Position) | Filing History |
| 2022-04-25 4:30 pm Purchase | 2022-04-13 | 13G | Aclaris Therapeutics, Inc. ACRS | RA Capital Management, L.P. | 4,398,453 7.100% | 4,398,453 (New Position) | Filing History |
| 2022-04-21 4:30 pm Purchase | 2022-04-11 | 13G | Veru Inc. VERU | RA Capital Management, L.P. | 7,900,000 9.870% | 7,900,000 (New Position) | Filing History |
| 2022-04-08 4:31 pm Purchase | 2022-03-29 | 13G | AN2 Therapeutics, Inc. ANTX | RA Capital Management, L.P. | 3,666,663 19.600% | 3,666,663 (New Position) | Filing History |
| 2022-04-01 4:30 pm Sale | 2022-03-30 | 13D | Kala Pharmaceuticals, Inc. KALA | RA Capital Management, L.P. | 436,585 15.030% | -1,877 (-0.43%) | Filing History |
| 2022-03-24 4:30 pm Purchase | 2022-03-14 | 13G | Standard BioTools Inc. LAB | RA Capital Management, L.P. | 4,651,177 6.000% | 4,651,177 (New Position) | Filing History |
| 2022-03-14 5:04 pm Purchase | 2022-03-10 | 13D | Cytek Biosciences, Inc. CTKB | RA Capital Management, L.P. | 13,139,327 9.800% | 2,057,164 (+18.56%) | Filing History |
| 2022-02-28 5:29 pm Purchase | 2022-02-28 | 13D | Cytek Biosciences, Inc. CTKB | RA Capital Management, L.P. | 11,082,163 8.300% | 1,475,135 (+15.35%) | Filing History |
| 2022-02-24 4:30 pm Purchase | 2022-02-14 | 13G | Vera Therapeutics, Inc. VERA | RA Capital Management, L.P. | 2,000,000 7.500% | 2,000,000 (New Position) | Filing History |
| 2022-02-18 4:36 pm Sale | 2021-12-31 | 13G | scPharmaceuticals Inc. SCPH | RA Capital Management, L.P. | 2,691,770 9.840% | -4,000,000 (-59.77%) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | RA Capital Management, L.P. | 2,850,000 5.900% | 0 (Unchanged) | Filing History |